No abstract

No abstract

Aim To design and present a new communication model “TAGEET” to help nurses engage therapeutically with patients suspected of or confirmed with COVID‐19. Background COVID‐19 is a highly contagious disease that brings with it fear and anxiety for all involved inclusive of nurses and patients. New guidelines for nurses to follow such as attention to physical distance coupled with the wearing of defined personal protective equipment, gloves, long‐sleeved disposable gown, FFP2 face mask and eye protection place additional strain on nurses to engage therapeutically with patients. Evidence suggests that the wearing of face masks and personal protective equipment acts as barriers to effective therapeutic engagement with patients. We found an absence of communication models to help nurses engage therapeutically with patients. Design This is a position paper that draws on previous research to inform the design of a new model for nurses to engage therapeutically with patients suspected of or confirmed with COVID‐19. Method We reviewed the literature on caring for patients in isolation, the barriers to therapeutic communication and the psychological impact of infectious diseases on nurses and patients. Conclusion Remaining emotionally present to self, whilst being present to others can be challenging for nurses in a pandemic environment. We believe that the “TAGEET” model (T—Tune‐in, A—Approach and introduce, G—Ground self, E—Engage and respond, E—End encounter, T—Tune‐out), although devised for nurses to engage therapeutically with patients suspected of or confirmed with COVID‐19 could be used by all healthcare professionals in any challenging clinical environment. Relevance to clinical practice This new therapeutic communication model will provide support for nurses with how to manage self in the context of caring for others in a COVID‐19 environment.

Early-life experiences provide the foundation for later cognitions and behaviors. The expanded FACE developmental model is useful in explaining emotions and coping styles across different age groups and countries. These data will also be used to generate an age-specific bank of items for the development of 3 (age-specific self-report, and parent proxy) questionnaires to assess emotions and coping in food allergy. Findings provide insight into how particular styles of coping develop and vary from patient to patient and may also guide clinician-patient communication and the development of individualized management strategies.

No abstract